Delivery Order SPE2DB24D2212-SPE2DB24FHMZQ

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 16,000 units of the medication PERTZYE DR 16,000 UNIT CAPSULE to the Defense Logistics Agency (DLA), a defense agency. The $26,094.23 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 13, 2024, with a completion date of March 14, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 units of PERTZYE DR 100S capsules, with a firm fixed price ceiling value of $24,368.76. The ultimate completion date for this delivery order is May 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,618.05, is for the delivery of 16,000 unit capsules of the drug PERTZYE DR. This is a Firm Fixed Price Delivery Order contract with a completion date of June 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 units of the medication PERTZYE DR Capsule, a treatment for exocrine pancreatic insufficiency. The contract is a firm fixed-price delivery order with a ceiling value of $3,798.45 and a period of performance through June 18, 2025. The contract is not set aside and was...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 units of PERTZYE DR 24,000 UNIT CAPSULE UU 80S, a pharmaceutical product. The contract has a firm fixed price of $7,757.79 and an ultimate completion date of June 26, 2025. The contract is not set aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $117,683.14 firm fixed-price contract is for the supply of PYLERA CAPSULE UU 120S, with a completion date of September 21, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999, which Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range...
This is a $43,130.46 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 270 count bottles of the drug Pirfenidone 267 mg tablets. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a $31,094.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and was not set aside for any specific business category. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB24FHMZQ
    Delivery Order

This is a $7,931.71 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 10, 2024. The contract is for the delivery of 24,000 unit capsules of the drug PERTZYE DR to support military healthcare programs.

The award is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

This particular delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for fulfilling the order. The contract has an ultimate completion date of July 11, 2024.

Generated 5/17/25, 9:56 AM